- Home
- AEVA vs MGTX Comparison
AEVA vs MGTX Comparison
Compare AEVA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- MGTX
- Stock Information
- Founded
- AEVA 2019
- MGTX 2015
- Country
- AEVA United States
- MGTX United States
- Employees
- AEVA N/A
- MGTX N/A
- Industry
- AEVA Auto Parts:O.E.M.
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AEVA Consumer Discretionary
- MGTX Health Care
- Exchange
- AEVA Nasdaq
- MGTX Nasdaq
- Market Cap
- AEVA 737.9M
- MGTX 670.2M
- IPO Year
- AEVA N/A
- MGTX N/A
- Fundamental
- Price
- AEVA $13.95
- MGTX $7.69
- Analyst Decision
- AEVA Strong Buy
- MGTX Strong Buy
- Analyst Count
- AEVA 5
- MGTX 2
- Target Price
- AEVA $20.80
- MGTX $24.00
- AVG Volume (30 Days)
- AEVA 2.8M
- MGTX 312.0K
- Earning Date
- AEVA 07-31-2025
- MGTX 08-14-2025
- Dividend Yield
- AEVA N/A
- MGTX N/A
- EPS Growth
- AEVA N/A
- MGTX N/A
- EPS
- AEVA N/A
- MGTX N/A
- Revenue
- AEVA $13,825,000.00
- MGTX $37,917,000.00
- Revenue This Year
- AEVA $110.19
- MGTX $145.67
- Revenue Next Year
- AEVA $96.22
- MGTX $167.61
- P/E Ratio
- AEVA N/A
- MGTX N/A
- Revenue Growth
- AEVA 111.39
- MGTX 366.84
- 52 Week Low
- AEVA $2.36
- MGTX $3.86
- 52 Week High
- AEVA $38.80
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- AEVA 41.77
- MGTX 50.13
- Support Level
- AEVA $12.86
- MGTX $7.15
- Resistance Level
- AEVA $17.29
- MGTX $7.75
- Average True Range (ATR)
- AEVA 1.27
- MGTX 0.38
- MACD
- AEVA 0.37
- MGTX -0.02
- Stochastic Oscillator
- AEVA 33.72
- MGTX 42.19
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.